HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$5.25
Day range
$5.17 - $5.44
Year range
$1.33 - $5.86
Market cap
958.68M USD
Avg Volume
2.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.82M | 29.23% |
Net income | -14.26M | -36.05% |
Net profit margin | — | — |
Earnings per share | -0.08 | 0.00% |
EBITDA | -15.80M | -30.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 219.90M | 62.40% |
Total assets | 231.26M | 55.05% |
Total liabilities | 21.65M | 101.30% |
Total equity | 209.61M | — |
Shares outstanding | 177.86M | — |
Price to book | 4.45 | — |
Return on assets | -22.73% | — |
Return on capital | -24.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -14.26M | -36.05% |
Cash from operations | -10.85M | 1.83% |
Cash from investing | -95.16M | -427.92% |
Cash from financing | 129.36M | 6,468,150.00% |
Net change in cash | 23.36M | 30.01% |
Free cash flow | -6.07M | 24.04% |
About
Founded
2014
Headquarters
Website
Employees
35
